过去一年中添加的文章,按日期排序
[PDF][PDF] ZBH2012001, a novel serotonin and norepinephrine reuptake inhibitor, exerts antidepressant effect via dual mechanism of monoamine enhancement and …
J ZHANG, Q FAN, ZY ZHANGSusu, S LUOYa… - cjpt.magtechjournal.com
2 天前 - … had a significant effect on the motor impairment caused by dopamine deple⁃ tion.
… effects of these drugs might be attributed to their actions on the monoamine system. 2.6 Effect …
… effects of these drugs might be attributed to their actions on the monoamine system. 2.6 Effect …
[HTML][HTML] Cannabinoid Modulation of Monoamine Levels in Mouse Brain: Unveiling Neurochemical Dynamics through an Innovative High-performance Liquid …
F Carla, C Susana, F Ricardo, LP Mariana… - Journal of Analysis and …, 2024 - Springer
15 天前 - … For example, deficits in noradrenergic, serotoninergic, and dopaminergic levels
have been observed in depression and Alzheimer’s disease, even though several other …
have been observed in depression and Alzheimer’s disease, even though several other …
[HTML][HTML] Behaviorally conditioned effects of psychoactive drugs in experimental animals: What we have learned from nearly a century of research and what remains to …
16 天前 - … their effects through dopaminergic pathways. It also covers dopamine receptor
agents … While antidepressants affecting rodent psychomotor activity are discussed, conditioned …
agents … While antidepressants affecting rodent psychomotor activity are discussed, conditioned …
Depression in Parkinson's disease is associated with dopamine unresponsive reduced reward sensitivity during effort-based decision making
H Costello, Y Yamamori, K Kieslich, M Murphy… - bioRxiv, 2024 - biorxiv.org
21 天前 - … Though noradrenergic function has been predominantly implicated in response
vigour … not rule out a role for the dopaminergic system in the aetiology of depression in PD, but …
vigour … not rule out a role for the dopaminergic system in the aetiology of depression in PD, but …
The Modulatory Role for Galanin Signaling in the VTA in Opioid Reward
25 天前 - … Despite this national emergency, there are only three FDA-approved medications
for the treatment of OUD, and each of these have side effects including respiratory depression…
for the treatment of OUD, and each of these have side effects including respiratory depression…
Time perception reflects individual differences in motor and non-motor symptoms of Parkinson's disease
K Kishida - Parkinsonism & Related Disorders, 2024 - prd-journal.com
30 天前 - … dopaminergic medications. We show that comorbid impulse control disorder is
associated with temporal overestimation; depression is … hypothesized dopaminergic mechanisms …
associated with temporal overestimation; depression is … hypothesized dopaminergic mechanisms …
Phytocannabinoids in neuromodulation: from omics to epigenetics
S Banerjee, D Saha, R Sharma, W Jayadee… - Journal of …, 2024 - Elsevier
35 天前 - … , dopaminergic synapse, and relaxin signalling. CBD protects against diseases like
epilepsy, depression, … The effects of phytocannabinoids vary across sex, disease state, and …
epilepsy, depression, … The effects of phytocannabinoids vary across sex, disease state, and …
Deciphering the therapeutic potential of SheXiangXinTongNing: Interplay between gut microbiota and brain metabolomics in a CUMS mice model, with a focus on …
X Wang, J Zhou, T Jiang, J Xu - Phytomedicine, 2024 - Elsevier
41 天前 - … antidepressant effects and underlying mechanisms. In this investigation, we assessed
XTN's antidepressant … , cAMP, calcium, and dopamine synapse signaling pathways. Our …
XTN's antidepressant … , cAMP, calcium, and dopamine synapse signaling pathways. Our …
Investigating the Effects of Antidepressants on Intestinal Bacteria
S Lebakken, CM Basting, M Bailey, T Schroeder… - 2024 - conservancy.umn.edu
45 天前 - … and dopamine reuptake inhibitor, bupropion; and one tetracyclic antidepressant, …
We calculated the concentration of drug needed to inhibit growth by 50% (IC50) using …
We calculated the concentration of drug needed to inhibit growth by 50% (IC50) using …
Targeting phosphodiesterase 4 as a potential therapy for Parkinson's disease: a review
PD Nongthombam, R Haobam - Molecular Biology Reports, 2024 - Springer
45 天前 - … disorders such as memory loss, depression, and Parkinson’s disease (PD). …
effects on PD, their possible underlying mechanism in the restoration/protection of dopaminergic …
effects on PD, their possible underlying mechanism in the restoration/protection of dopaminergic …